Xenon Pharmaceuticals Inc (XENE)
38.69
-0.21
(-0.54%)
USD |
NASDAQ |
Dec 20, 16:00
38.64
-0.05
(-0.13%)
After-Hours: 20:00
Xenon Pharmaceuticals Shareholders Equity (Quarterly): 797.81M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 388.00M |
| Edesa Biotech Inc | 1.981M |
| Lexaria Bioscience Corp | 8.036M |
| ESSA Pharma Inc | 124.61M |
| ImmunoPrecise Antibodies Ltd | 23.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 835.90M |
| Total Liabilities (Quarterly) | 38.09M |